RGD Forever!—Past, Present, and Future of a 3-Letter-Code in Radiopharmacy and Life Sciences
“RGD” is frequently pictured as a ligand for αvβ3-integrin and useful for molecular targeting of angiogenesis—which is about as simplistic as the idea that laser beams are green or red and particularly useful for arming spaceships. There is, however, much more to RGD. In particular, targeting angiog...
Main Author: | Johannes Notni |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-12-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/16/1/56 |
Similar Items
-
Characterization of iRGD-Ligand Modified Arginine-Histidine-Rich Peptides for Nucleic Acid Therapeutics Delivery to αvβ3 Integrin-Expressing Cancer Cells
by: Anna Egorova, et al.
Published: (2020-10-01) -
RGD-based self-assembling nanodrugs for improved tumor therapy
by: Bin Wang, et al.
Published: (2024-10-01) -
iRGD-Targeted Peptide Nanoparticles for Anti-Angiogenic RNAi-Based Therapy of Endometriosis
by: Anna Egorova, et al.
Published: (2023-08-01) -
Synthesis and Evaluation of a Dimeric RGD Peptide as a Preliminary Study for Radiotheranostics with Radiohalogens
by: Hiroaki Echigo, et al.
Published: (2021-10-01) -
Development of iRGD-Modified Peptide Carriers for Suicide Gene Therapy of Uterine Leiomyoma
by: Anna Egorova, et al.
Published: (2021-02-01)